These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5311002)

  • 1. Similarities between behavioral and pharmacological actions of yohimbine and 5-hydroxytryptophan in the conscious dog.
    Sanghvi I; Gershon S
    Eur J Pharmacol; 1970 Jul; 11(2):125-9. PubMed ID: 5311002
    [No Abstract]   [Full Text] [Related]  

  • 2. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
    Martin WR; Eades CG
    Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

  • 5. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 8. Similarities between the pharmacological actions of quipazine and serotonin.
    Hong E; Sancilio LF; Vargas R; Pardo EG
    Eur J Pharmacol; 1969; 6(3):274-80. PubMed ID: 5816391
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
    Hirschhorn ID; Rosecrans JA
    Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity.
    Banna NR; Anderson EG
    J Pharmacol Exp Ther; 1968 Aug; 162(2):319-25. PubMed ID: 5302116
    [No Abstract]   [Full Text] [Related]  

  • 11. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of central nervous system stimulants in a new laboratory test for antidepressants.
    Sanghvi I; Gershon S
    Life Sci; 1969 May; 8(9):449-57. PubMed ID: 4389344
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials.
    Wilkison DM; Hosko MJ
    Exp Neurol; 1983 Nov; 82(2):391-403. PubMed ID: 6628626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of 5-hydroxytryptamine and narcotic analgesics on dog intestine in vivo.
    de Oliveira LF; Sollero L
    Pharmacology; 1973; 10(5):291-7. PubMed ID: 4764535
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
    Lapin IP; Oxenkrug GF; Azbekyan SG
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):350-61. PubMed ID: 4260601
    [No Abstract]   [Full Text] [Related]  

  • 16. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
    Antonaccio MJ; Robson RD
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
    [No Abstract]   [Full Text] [Related]  

  • 17. A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.
    Corne SJ; Pickering RW
    Psychopharmacologia; 1967; 11(1):65-78. PubMed ID: 5302272
    [No Abstract]   [Full Text] [Related]  

  • 18. "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.
    Bedard P; Pycock CJ
    Neuropharmacology; 1977 Oct; 16(10):663-70. PubMed ID: 304190
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploration of the anti-depressant potential of lithium.
    Geyer H; Sanghvi I; Gershon S
    Psychopharmacologia; 1973 Jan; 28(2):107-13. PubMed ID: 4735134
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo antiserotonin activity in the unanesthetized guinea pig.
    McKeon WB
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):373-82. PubMed ID: 6049331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.